The aporphine alkaloids (+)-dicentrine and (+)-bulbocapnine are non-planar
molecules lacking features normally associated with DNA binding by intercal
ation or minor groove binding. Surprisingly, dicentrine showed significant
activity as a topoisomerase II (EC 5.99.1.3) inhibitor and also was active
in a DNA unwinding assay. The DNA unwinding suggests DNA intercalation, whi
ch could explain the inhibition of topoisomerase II. Bulbocapnine, which di
ffers from dicentrine only by the presence of a hydroxyl group at position
11 and the absence of a methoxyl group at position 9, was inactive in all a
ssays. Molecular modeling showed that dicentrine can attain a relatively pl
anar conformation, whereas bulbocapnine cannot, due to steric interaction b
etween the Il-hydroxyl group and an oxygen of the methylenedioxy ring. Thes
e observations suggest that dicentrine is an "adaptive" DNA intercalator, w
hich can bind DNA only by adopting a somewhat strained planar conformation.
The requirement uf a suboptimal conformation to achieve DNA binding appear
s to make dicentrine a weaker topoisomerase II inhibitor than the very plan
ar oxoaporphine alkaloid liriodenine. These results suggest that it may be
possible to modulate DNA binding and biologic activity of drugs by modifica
tions affecting their ability to adopt planar conformations. (C) 1999 Elsev
ier Science Inc.